CD56bright natural killer cell expansion and response to daclizumab HYP treatment in relapsing-remitting multiple sclerosis

Authors
Category Primary study
ConferenceJournal of Neurology
Year 2012
This article has no abstract
Epistemonikos ID: b2b806be6a303de8f20a85601adad30f33ebad2e
First added on: Apr 30, 2026